Acute ketamine administration alters the brain responses to executive demands in a verbal working memory task: An fMRI study

Neuropsychopharmacology

Volumn 29, Issue 6, 2004, Pages 1203-1214

  Honey, R A E ^a   Honey, G D ^a   O'Loughlin, C ^a   Sharar, S R ^b   Kumaran, D ^a   Bullmore, E T ^a   Menon, D K ^a   Donovan, T ^c   Lupson, V C ^a   Bisbrown Chippendale, R ^a   Fletcher, P C ^a,d  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b UNIVERSITY OF WASHINGTON   (United States)

^c SAINT MARTIN'S UNIVERSITY   (United States)

^d UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

fMRI; Ketamine; Psychopharmacology; Schizophrenia; Working memory

Indexed keywords

KETAMINE;

ADULT; ARTICLE; BRAIN FUNCTION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; FRONTAL CORTEX; HUMAN; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PARIETAL LOBE; PRIORITY JOURNAL; PUTAMEN; RANDOMIZED CONTROLLED TRIAL; STATISTICAL SIGNIFICANCE; VERBAL COMMUNICATION; WORKING MEMORY;

ADULT; ANALYSIS OF VARIANCE; BRAIN; BRAIN MAPPING; DECISION MAKING; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; EXCITATORY AMINO ACID ANTAGONISTS; FEMALE; HUMANS; KETAMINE; MAGNETIC RESONANCE IMAGING; MALE; MEMORY, SHORT-TERM; MIDDLE AGED; REACTION TIME; TIME FACTORS; VERBAL LEARNING;

EID: 2442693864     PISSN: 0893133X     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.npp.1300438     Document Type: Article

References (59)

1. Adler CM, Goldberg TE, Malhotra AK, Pickar D, Breier A (1998). Effects of ketamine on thought disorder, working memory, and semantic memory in healthy volunteers. Biol Psychiatry 43: 811-816.
2. Ashburner J, Friston KJ (1999). Nonlinear spatial normalization using basis functions. Hum Brain Mapp 7: 254-266.
3. Baddeley AD (1986). Working Memory. Clarendon Press: Oxford, UK.
4. Baddeley AD, Hitch GJ (1994). Developments in the concept of working memory. Neuropsychology 8: 485-493.
5. Braver TS, Cohen JD, Nystrom LE, Jonides J, Smith EE, Noll DC (1997). A parametric study of prefrontal cortex involvement in human working memory. Neuroimage 5: 49-62.
6. Breier A, Malhotra AK, Pinals DA, Weisenfeld NI, Pickar D (1997). Association of ketamine-induced psychosis with focal activation of the prefrontal cortex in healthy volunteers. Am J Psychiatry 154: 805-811.
7. Bressi S, Miele L, Bressi C, Astori S, Gimosti E, Linciano AD et al (1996). Deficit of central executive component of working memory in schizophrenia. N Trends Exp Clin Psychiatry 12: 243-252.
8. Burgess PW (1997). Theory and methodology in executive function research. In Rabbitt P (eds). Methodology of Frontal and Executive Function. Psychology Press: Hove. pp 81-116.
9. Callicott JH, Mattay VS, Bertolino A, Finn K, Coppola R, Frank JA et al (1999). Physiological characteristics of capacity constraints in working memory as revealed by functional MRI. Cerebr Cortex 9: 20-26.
10. Callicott JH, Ramsey NF, Tallent K, Bertolino A, Knable MB, Coppola R et al (1998). Functional Magnetic Resonance Imaging brain mapping in psychiatry: methodological issues illustrated in a study of working memory in schizophrenia. Neuropsychopharmacology 18: 186-196.
11. Carlsson A, Hansson LO, Waters N, Carlsson ML (1999). A glutamatergic deficiency model of schizophrenia. Br J Psychiatry 174(Suppl 37): 2-6.
12. Carter CS, Perlstein W, Ganguli R, Brar J, Mintun M, Cohen JD (1998). Functional hypofrontality and working memory dysfunction in schizophrenia. Am J Psychiatry 155: 1285-1287.
13. Cocosco CA, Kollokian V, Kwan RKS, Evans AC (1997). Brainweb: online interface to a 3D MRI simulated brain database. Neuroimage 5: 425.
14. Cohen JD, Perlstein WM, Braver TS, Nystrom LE, Noll DC, Jonides J et al (1997). Temporal dynamics of brain activation during a working memory task. Nature 386: 604-608.
15. Conklin HM, Curtis CE, Katsanis J, Iacono WG (2000). Verbal working memory impairment in schizophrenia patients and their first-degree relatives: evidence from the digit span task. Am J Psychiatry 157: 275-277.
16. Curtis VA, Bullmore ET, Brammer MJ, Wright IC, Williams SC, Sharma TS et al (1998). Attenuated frontal activation during a verbal fluency task in patients with schizophrenia. Am J Psychiatry 155: 1056-1063.
17. D'Esposito M, Postle BR, Ballard D, Lease J (1999). Maintenance versus manipulation of information held in working memory: an event-related fMRI study. Brain Cognition 41: 66-86.
18. De Zubicaray GI, Williams SCR, Wilson SJ, Rose SE, Brammer MJ, Bullmore ET et al (1998). Prefrontal cortex involvement in selective letter generation: a functional magnetic resonance imaging study. Cortex 34: 389-401.
19. Domino EF, Zsigmond EK, Domino LE, Domino KE, Kothary SP, Domino SE (1982). Plasma levels of ketamine and two of its metabolites in surgical patients using a gas chromatographic mass fragmentographic assay. Anesthesia Analgesia 61: 87-92.
20. Fletcher PC, Henson RNA (2001). Frontal lobes and human memory: insights from functional neuroimaging. Brain 124: 849-881.
21. Friedman HR, Goldman-Rakic PS (1994). Coactivation of prefrontal cortex and inferior parietal cortex in working memory tasks revealed by 2DG functional mapping in the rhesus monkey. J Neurosci 14: 2775-2788.
22. Friston KJ, Holmes AP, Worsley KJ, Poline J-B, Frith CD, Frackowiak RSJ (1995). Statistical parametric maps in functional imaging: a general linear approach. Hum Brain Mapp 2: 189-210.
23. Genovese CR, Lazar NA, Nichols T (2002). Thresholding of statistical maps in functional neuroimaging using the false discovery rate. Neuroimage 15: 870-878.
24. Gepts E (1998). Pharmacokinetic concepts for TCI anaesthesia. Anaesthesia 53(Suppl 1): 4-12.
25. Ghoneim MM, Hinrichs JV, Mewaldt SP, Petersen RC (1985). Ketamine: behavioral effects of subanesthetic doses. J Clin Psychopharmacol 5: 70-77.
26. Gold JM, Harvey PD (1993). Cognitive deficits in schizophrenia. Psychiatr Clin N Am 16: 295-312.
27. Goldman-Rakic PS (1996). The prefrontal landscape: implications of functional architecture for understanding human mentation and the central executive. Philosoph Trans R Soc London B 351: 1445-1453.
28. Gooding DC, Tallent KA (2002). Spatial working memory performance in patients with schizoaffective psychosis versus schizophrenia: a tale of two disorders? Schizophrenia Res 53: 209-218.
29. Hirsch SR, Das I, Garey LJ, deBelleroche J (1997). A pivotal role for glutamate in the pathogenesis of schizophrenia, and its cognitive dysfunction. Pharmacol Biochem Behavr 56: 797-802.
30. 15O demonstrate ketamine actions in CNS dynamically. Neuropsychopharmacology 25: 165-172.
31. Honey RAE, Turner DC, Honey GD, Sharar SR, Kumaran D, Pomarol-Clotet E et al (2003). Low dose ketamine produces a deficit in manipulation but not maintenance of the contents of working memory. Neuropsychopharmacology 28: 2037-2044.
32. Javitt DC, Zukin SR (1991). Recent advances in the phencyclidine model of schizophrenia. Am J Psychiatry 148: 1301-1308.
33. Jentsch JD, Roth RH (1999). The neuropsychopharmacology of phencyclidine: from NMDA receptor hypofunction to the dopamine hypothesis of schizophrenia. Neuropsychopharmacology 20: 201-225.
34. Jonides S, Schumacher EH, Smith EE, Lauber EJ, Awh E, Minosiima J et al (1997). Verbal working memory load affects regional brain activation as measured by PET. J Cogni Neurosci 9: 462-475.
35. Kegeles LS, Abir-Dargham A, Zea-Ponce Y, Rodenhiser-Hill J, Mann JJ, Van Heertum RL et al (2000). Modulation of amphetamine-induced striatal dopamine release by ketamine in humans: implications for schizophrenia. Biol Psychiatry 48: 627-640.
36. Kharasch ED, Labroo R (1992). Metabolism of ketamine stereoisomers by human liver microsomes. Anesthesiology 77: 1201-1207.
37. Krystal JH, Abi-Dargham A, Laruelle M, Moghaddam B (1999). Pharmacologic models of psychoses. In Charney DS, Nestler EJ, Bunney BS (eds). Neurobiology of Mental Illness, pp 214-224, Oxford University Press: New York, NY.
38. Krystal JH, Karper LP, Seibyl JP, Freeman GK, Delaney R, Bremner JD et al (1994). Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses. Arch Gen Psychiatry 51: 199-214.
39. Lahti AC, Koffel B, LaPorte D, Tamminga CA (1995). Subanesthetic doses of ketamine stimulate psychosis in schizophrenia. Neuropsychopharmacology 13: 9-19.
40. Mahurin RK, Velligan DI, Miller AL (1998). Executive-frontal lobe cognitive dysfunction in schizophrenia: a symptom subtype analysis. Psychiatry Res 79: 139-149.
41. Manoach DS, Gollub RL, Benson ES, Searl MM, Goff DC, Halpern E et al (2000). Schizophrenic subjects show aberrant fMRI activation of dorsolateral prefrontal cortex and basal ganglia during working memory performance. Biol Psychiatry 48: 99-109.
42. Manoach DS, Press DZ, Thangaraj V, Searl MM, Goff DC, Halpern E et al (1999). Schizophrenic subjects activate dorsolateral prefrontal cortex during a working memory task, as measured by fMRI. Biol Psychiatry 45: 1128-1137.
43. Menon V, Anagnoson RT, Mathalon DH, Glover GH, Pfefferbaum A (2001). Functional neuroanatomy of auditory working memory in schizophrenia: relation to positive and negative symptoms. NeuroImage 13: 433-446.
44. Moghaddam B, Adams B, Verma A, Daly D (1997). Activation of glutamatergic neurotransmission by ketamine: a novel step in the pathway from NMDA receptor blockade to dopaminergic and cognitive disruptions associated with the prefrontal cortex. J Neurosci 17: 2921-2927.
45. Morice R, Delahunty A (1996). Frontal/executive impairments in schizophrenia. Schizophrenia Bull 22: 125-137.
46. Nelson HE (1991). National Adult Reading Test. NFER-Nelson Publishing: Berkshire, UK.
47. Olney JW, Farber NB (1995). Glutamate receptor dysfunction and schizophrenia. Arch of Gen Psychiatry 52: 998-1007.
48. Oye I, Paulsen O, Maurset A (1992). Effects of ketamine on sensory perception: evidence for a role of N-methyl-D-aspartate receptors. J Pharmacol Exp Ther 260: 1209-1213.
49. Pantelis C, Barnes TRE, Nelson HE, Tanner S, Weatherley L, Owen AM et al (1997). Frontal-striatal cognitive deficits in patients with chronic schizophrenia. Brain 120: 1823-1843.
50. Park S, Holzman PS (1992). Schizophrenics show spatial working memory deficits. Arch Gen Psychiatry 49: 975-982.
51. Postle BR, Berger JS, D'Esposito M (1999). Functional neuroanatomical double dissociation of mnemonic and executive control processes contributing to working memory performance. Proc Natl Acad Science USA 96: 12959-12964.
52. Smith EE, Jonides J, Koeppe RA (1996). Dissociating verbal and spatial working memory using PET. Cerebr Cortex 6: 11-20.
53. 11C-raclopride in normal human subjects. Neuropsychopharmacology 18: 18-25.
54. Tamminga C (1999). Glutamatergic aspects of schizophrenia. Br J Psychiatry 174(Suppl 37): 12-15.
55. Tamminga CA (1998). Schizophrenia and glutamatergic transmission. Crit Rev Neurobiol 12: 21-36.
56. Tek C, Gold J, Blaxton T, Wilk C, McMahon RP, Buchanan RW (2002). Visual perceptual and working memory impairments in schizophrenia. Arch Gen Psychiatry 59: 146-153.
57. Tsai G, Coyle JT (2002). Glutamatergic mechanisms in schizophrenia. Ann Rev Pharmacol Toxicol 42: 165-179.
58. Vollenweider FX, Leenders KL, Oye I, Hell D, Angst J (1997a). Differential psychopathology and patterns of cerebral glucose utilisation produced by (S)- and (R)-ketamine in healthy volunteers using positron emission tomography (PET). Eur Neuropsychopharmacol 7: 25-38.
59. 18F]fluorodeoxyglucose (FDG). Eur Neuropsychopharmacol 7: 9-24.